Carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) are the most studied tumor markers in pancreatic cancer and are both associated with disease stage and overall survival (OS) in patients who underwent pancreatic tumor resection. The gene discussed is CEACAM5; the disease is neoplasm.